Exporting the NHS 'brand' overseas?

British hospitals are being encouraged to sell their services abroad. But Healthcare UK, created to oversee this move into the foreign market, won't reflect the real NHS 'brand', rooted as it is in the human right to health.

Lara Brearley
4 September 2012

Dubai Health City, pictured, includes a branch of London's Moorfields Eye Hospital

With all the hype – and criticism – last week around the announcement of Healthcare UK, I was surprised to see nothing that questioned whether this initiative truly promoted the ‘brand’ of the NHS. I first thought it was an issue of semantics – what does ‘brand’ really mean? As a term typically used in advertising, was I just misunderstanding? But I’m not so sure that I am. 

If the brand of the NHS is its reputation, what it is identified as, then my pride in the NHS is the fact that it’s a publicly financed service which provides essential healthcare to all people, free at the point of use. It ensures that access to healthcare is determined by need, not ability to pay. The core principles that define the very fabric of the NHS are solidarity and the human right to health.

A contradiction of values

I don’t think I’m alone on this one. Based on his opening ceremony at the Olympics, I’d imagine Danny Boyle would agree, along with many of those who were watching. Even the Secretary of State for Health, Andrew Lansley, celebrated these values – universality, free to all, based on need, and social solidarity – in his speech to the World Health Assembly (WHA) in May earlier this year.

From what I can see, Healthcare UK is in clear contradiction of what we value most about the NHS. Exploiting the brand for profit overseas will benefit the wealthy first and foremost – giving access to quality care to those with the ability to pay. This is unfair, and to claim that it reflects the ‘brand’ of the NHS is simply inaccurate. Further, it’s the core principles of the NHS that we should be exporting abroad, to countries where the basic right to health is not met, not private health services that charge user fees – the most regressive form of financing.

An opportunity to promote NHS principles

As Andrew Lansley noted in his speech to the WHA, “Millions of poor people fall ill and die due to diseases and conditions that are preventable and treatable." He continued, “Out-of-pocket costs stop many of these people getting the help they need. The solution is efficient and effective healthcare that does not exclude or impoverish the poor.” 

The Department for International Development (DFID) has done a lot to support countries to develop and implement more equitable health financing policies, for instance, supporting the removal of user fees for women and children in Sierra Leone. With the growing momentum of universal health coverage and increasing numbers of low- and middle-income countries taking steps towards this, the UK government has an opportunity to demonstrate its commitment to the NHS by promoting its principles abroad. Healthcare UK is certainly not the way forward.

This piece was originally published on the Save the Children website. 

Stop the secrecy: Publish the NHS COVID data deals

To: Matt Hancock, Secretary of State for Health and Social Care

We’re calling on you to immediately release details of the secret NHS data deals struck with private companies, to deliver the NHS COVID-19 datastore.

We, the public, deserve to know exactly how our personal information has been traded in this ‘unprecedented’ deal with US tech giants like Google, and firms linked to Donald Trump (Palantir) and Vote Leave (Faculty AI).

The COVID-19 datastore will hold private, personal information about every single one of us who relies on the NHS. We don’t want our personal data falling into the wrong hands.

And we don’t want private companies – many with poor reputations for protecting privacy – using it for their own commercial purposes, or to undermine the NHS.

The datastore could be an important tool in tackling the pandemic. But for it to be a success, the public has to be able to trust it.

Today, we urgently call on you to publish all the data-sharing agreements, data-impact assessments, and details of how the private companies stand to profit from their involvement.

The NHS is a precious public institution. Any involvement from private companies should be open to public scrutiny and debate. We need more transparency during this pandemic – not less.

By adding my name to this campaign, I authorise openDemocracy and Foxglove to keep me updated about their important work.

Who is bankrolling Britain's democracy? Which groups shape the stories we see in the press; which voices are silenced, and why? Sign up here to find out.


We encourage anyone to comment, please consult the oD commenting guidelines if you have any questions.
Audio available Bookmark Check Language Close Comments Download Facebook Link Email Newsletter Newsletter Play Print Share Twitter Youtube Search Instagram WhatsApp yourData